论文信息 - LO8 : Daclatasvir, sofosbuvir, and ribavirin combination for HCV patients with advanced cirrhosis or posttransplant recurrence: Phase 3 ALLY-1 study - 字舞流文

LO8 : Daclatasvir, sofosbuvir, and ribavirin combination for HCV patients with advanced cirrhosis or posttransplant recurrence: Phase 3 ALLY-1 study

E. Schiff | F. Poordad | F. Mcphee | E. Hughes | S. Noviello | J. Vierling | E. Swenson | C. Landis | R. Fontana | R. Yang